Leading Financial Service Provider in India | Canara Bank Securities Ltd

AstraZeneca Pharma India Ltd.

Aug 08 BSE 8765.10 (+ 36.60 0.42%)

Volume702

Prev. Close
8728.50

Open Price
8756.45

Today's Low / High

8693.70 8880.75

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

6222.35 10653.05

Aug 08 NSE 8784.50(+ 61.00 0.70%)

Volume15302

Prev. Close
8723.50

Open Price
8750.00

Today's Low / High

8661.00 8888.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

6220.00 10691.00

Market Cap. ( ₹ in Cr. )	21961.25	P/BV	32.33	Book Value ( ₹ )	271.74
52 Week High/Low ( ₹ )	10691/6220	FV/ML	2/1	P/E(X)	189.75
Book Closure	18/07/2025	EPS ( ₹ )	46.30	Div Yield (%)	0.36

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00


INCOME
Revenue From Operations [Net]	1713.29	1295.53	1002.97	805.60	813.56
Other Operating Revenues	3.00	0.00	0.00	0.00	0.00
Total Operating Revenues	1716.29	1295.53	1002.97	805.60	813.56

Other Income	40.63	34.80	26.10	14.76	12.84
Total Revenue	1756.92	1330.33	1029.07	820.36	826.40

EXPENSES
Cost Of Materials Consumed	287.13	129.02	84.38	89.61	97.26
Purchase Of Stock-In Trade	1008.82	499.31	324.46	207.88	194.74
Changes In Inventories Of FG,WIP And Stock-In Trade	-332.94	-33.77	-48.86	14.47	2.95
Employee Benefit Expenses	257.44	241.45	259.10	230.21	219.54
Finance Costs	1.46	1.20	0.63	0.95	1.09
Depreciation And Amortisation Expenses	39.99	14.94	16.26	16.95	20.13
Other Expenses	241.87	275.07	218.77	177.25	163.60
Total Expenses	1503.77	1127.22	854.74	737.32	699.31

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	253.15	203.11	174.33	83.04	127.09

Exceptional Items	-96.79	16.43	-40.23	0.00	0.00
Profit/Loss Before Tax	156.36	219.54	134.10	83.04	127.09

Tax Expenses-Continued Operations
Current Tax	60.10	53.55	38.30	22.63	34.83
Deferred Tax	-19.92	-0.90	-3.49	-1.19	-1.04
Tax For Earlier Years	0.44	5.38	0.00	0.00	0.00
Total Tax Expenses	40.62	58.03	34.81	21.44	33.79
Profit/Loss After Tax And Before ExtraOrdinary Items	115.74	161.51	99.29	61.60	93.30

Profit/Loss From Continuing Operations	115.74	161.51	99.29	61.60	93.30

Profit/Loss For The Period	115.74	161.51	99.29	61.60	93.30

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	46.30	64.60	39.70	24.60	37.30
Diluted EPS (Rs.)	46.30	64.60	39.70	24.60	37.30

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	60.00	40.00	20.00	5.00	5.00
Equity Dividend Rate (%)	1600.00	1200.00	800.00	500.00	100.00

Markets

Income Statement

INCOME STATEMENT

AstraZeneca Pharma India Ltd.